Context and biological diversity
Endometrial cancer should be separated from uterine sarcomas and cervical tumors. Histology, grade and anatomical extent describe important components but do not exhaust biological diversity. DNA repair status and molecular alterations can define relevant groups for organizing cohorts and comparing findings.
What research makes it possible to study
TCGA described four molecular classes of endometrial carcinomas, including POLE-related ultramutated tumors, hypermutated tumors and groups with lower or higher copy-number alteration. This work grounded stratification questions. Applying a classification through surrogate assays requires explaining how each group was operationalized.
Application in a research project
A project can assess agreement between a research classification and a set of tests accessible in routine practice. Unclassifiable cases and discrepancies between laboratories need recording. Recurrence research should keep stage, treatment and follow-up duration visible to separate marker associations from selection differences.
Research questions
Does a simplified laboratory strategy reproduce the reference classification in an external cohort?
- Study design
- An agreement study with blinded assessment, a fixed algorithm and participation from more than one laboratory.
- What to measure
- Agreement by group, indeterminate results, reproducibility and material quality.
- Interpretation limits
- Analytical agreement does not prove clinical utility. Endometrial carcinoma findings should not be applied to other uterine neoplasms.
Interpretation limits
Analytical agreement does not prove clinical utility. Endometrial carcinoma findings should not be applied to other uterine neoplasms.
Original references
Continue exploring
Research questions
Educational content for framing research. Consult the original document, study population and methodology before interpreting a conclusion. Methodology